Citi views the recent volatility in shares of Royalty Pharma (RPRX) as a buying opportunity. Worries over the tariff impact to biopharma have ...

January 10, 2025 Royalty Pharma simplifies corporate structure with $1.1 bln deal Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that ...

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...